A homology model of the dopamine D 2 receptor was constructed based on the crystal structure of rhodopsin. A putative sodium-binding pocket identified in an earlier model (PDB 1I15) was revised. It is now defined by Asn-419 backbone oxygen at the apex of a pyramid and Asp-80, Ser-121, Asn-419, and Ser-420 at each vertex of the planar base. Asn-423 stabilizes this pocket through hydrogen bonds to two of these residues. Highly conserved Asn-52 is positioned near the sodium pocket, where it hydrogen-bonds with Asp-80 and the backbone carbonyl of Ser-420. Mutation of three of these residues, Asn-52 in helix 1, Ser-121 in helix 3, and Ser-420 in helix 7, profoundly altered the properties of the receptor. Mutants in which Asn-52 was replaced with Ala or Leu or Ser-121 was replaced with Leu exhibited no detectable binding of radioligands, although receptor immunoreactivity in the membrane was similar to that in cells expressing the wild-type D 2L receptor. A mutant in which Asn-52 was replaced with Gln, preserving hydrogen-bonding capability, was similar to D 2L in affinity for ligands and ability to inhibit cAMP accumulation. Mutants in which either Ser-121 or Ser-420 was replaced with Ala or Asn had decreased affinity for agonists (Ser-121), but increased affinity for the antagonists haloperidol and clozapine. Interestingly, the affinity of these Ser-121 and Ser-420 mutants for substituted benzamide antagonists showed little or no dependence on sodium, consistent with our hypothesis that Ser-121 and Ser-420 contribute to the formation of a sodium-binding pocket.
The dopamine D 2 receptor belongs to a subfamily of 7-transmembrane domain (TM) G protein-coupled receptors that interact with the G proteins G␣ i and G␣ o to modulate several effectors, including adenylate cyclase and potassium channels (Limbird, 1988) . A characteristic of G␣ i -coupled receptors is that they are regulated by sodium, which decreases the affinity of the receptors for agonists (Pert and Snyder, 1974; Limbird et al., 1982) . Sodium inhibits the binding of agonists by acting directly on the receptor (Limbird et al., 1982; Urwyler, 1989) at a site that is accessible from the intracellular surface of the cell membrane (Motulsky and Insel, 1983; Nunnari et al., 1987) . Although the binding of antagonist ligands to some G␣ i -coupled receptors is modestly enhanced (Ͻ10-fold) by sodium (Limbird et al., 1982) , the D 2 receptor is unusual in that the affinity of certain antagonists, most of them substituted benzamide derivatives, is enhanced 10-to 40-fold by sodium (Stefanini et al., 1980; Neve, 1991) .
Homology modeling of the dopamine D 2 receptor (Teeter et al., 1994) has suggested the presence of a pyramidal sodiumbinding pocket defined by residues Asp-80 2.50 , Ser-121 3.39 , at each vertex of the base, and 7.49 at the apex. Asn-52 1.50 is positioned near the sodium pocket, where it could interact with Asp-80. This putative sodium regulatory site is contiguous with a proposed nonpolar binding pocket; an attractive hypothesis is that drugs that occupy the nonpolar binding pocket may be particularly sensitive to the binding of sodium to the regulatory site (Teeter et al., 1994; Teeter and DuRand, 1996) .
Mutation of Asp-80 of the D 2 receptor and the corresponding residue in the ␣ 2A -adrenergic receptor, one of the putative sodium pocket residues, abolishes regulation of these receptors by sodium (Horstman et al., 1990; Neve et al., 1991) . This highly conserved TM2 residue has been a frequent target of mutagenesis studies, having been mutated in at least 31 different receptor subtypes (Beukers et al., 1999) .
In addition to eliminating regulation of receptors by sodium (Horstman et al., 1990; Neve et al., 1991; Barbhaiya et al., 1996; Martin et al., 1999) , mutation of this residue eliminates or greatly reduces functional coupling of many receptors to G proteins and second messengers (Chung et al., 1988; Fraser et al., 1989; Neve et al., 1991; Perlman et al., 1997a; Donnelly et al., 1999; Martin et al., 1999) . Thus, binding of sodium to this residue may be important for stabilizing an active receptor conformation.
We now describe a revised D 2 receptor model, derived from the newly determined X-ray structure of rhodopsin, in which 7.45 replaces Asn-124 at one vertex of the pyramidal sodium-binding pocket and the carbonyl of Asn-419 replaces Asn-423 at the apex. Mutation of three additional residues within this region, Asn-52 in TM1, Ser-121 in TM3, and Ser-420 in TM7, profoundly altered the properties of the receptor. We constructed mutant receptors in which Asn-52 of the rat D 2L was replaced with alanine (N52A), leucine (N52L), or glutamine (N52Q), and Ser-121 was replaced with alanine (S121A), asparagine (S121N), or leucine (S121L). The mutants N52A, N52L, and S121L exhibited no detectable binding of radioligands, although receptor targeting to the plasma membrane did not appear grossly impaired. The mutant N52Q, which retains hydrogen-bonding capability at this residue, was similar to the wild-type receptor in affinity for ligands and ability to inhibit adenylate cyclase. S121A and S121N had decreased affinity for agonists but increased affinity for the antagonists haloperidol and clozapine. Interestingly, the binding of substituted benzamide antagonists to S121A and S121N showed a loss of sodium sensitivity, with decreased binding compared with wild-type D 2L only in the presence of sodium. A similar loss of sodium sensitivity was observed for Ser-420 mutants (S420A, S420N, S420L, and S420V) but not for mutants of a residue now predicted to be oriented away from the putative sodium-binding pocket, Asn-124 (N124A, N124L, N124Q). Modeling. An initial model of the D 2 receptor was built from the two-dimensional electron microscopy structure of bacteriorhodopsin, as described previously (Teeter et al., 1994) . In brief, based on the three-dimensional bacteriorhodopsin structure obtained experimentally and related adrenergic receptor ligand binding mutagenesis, rhodopsin was aligned with bacteriorhodopsin. Alignment of low homology sequences was aided by establishing polar and nonpolar helix faces via helical wheels. From the alignment, D 2 receptor residues were substituted into the coordinates of bacteriorhodopsin (Henderson et al., 1990) to build an initial data-based D 2 receptor model. Local geometry optimization, Pro template replacements, and side chain rotation consistent with protein structure knowledge refined this model (1I15 in the Protein Data Bank). Global energy minimization was not used for the final model for reasons discussed previously (see footnote 1 in Teeter et al., 1994 ).
Experimental Procedures
An improved model was based on the rhodopsin X-ray structure at 2.8-Å resolution (Palczewski et al., 2000) . The sequence alignment was straightforward and identical to that of the online "Comprehensive alignment of G protein-coupled receptor sequences" (http:// mgddk1.niddk.nih.gov:8000/comprehensive.html). Residues in rhodopsin were substituted with rat D 2L residues. Unless otherwise specified, residues are numbered according to their position in the receptor being discussed. In some cases, a superscript is added to indicate the position of the residue relative to the most conserved residue in that TM (Ballesteros and Weinstein, 1995) Modeling the Pro residues required consideration of the structural location and geometry of the Pro. Of the changed residues, Pro-53 1.48 is not significantly bent in rhodopsin (Palczewski et al., 2000) . The backbone of this residue, changed to Phe in the D2 receptor, was not remodeled. Residues that were different from rhodopsin in the termini or loops (one in the nonhelical N terminus region, one in cytoplasmic loop 1 between TM1 and TM2, two in extracellular loop 2 between TM4 and TM5, 11 in cytoplasmic loop 3, and one in extracellular loop 3) were not modeled, because loops are not included at this time. Five of the seven remaining Pro changes were at the N terminus of helices 1, 2, 3, 5, and 7 (1.29, 2.38, 3.22, 5.36, 7.31) , were considered to be involved in the turns, and were not modeled. The same reasoning was applied to the Pro 4.60 at the C-terminus of TM4. Pro-89 2.59 replaced a Thr that, in the rhodopsin crystal structure, is near the kink and helix unwinding at Gly 2.56 -Gly 2.57 (Palczewski et al., 2000) . This kink on the N-terminal side of Pro-89 2.59 in D2 eliminates most bad contacts in the Pro side chain direction. Only small backbone torsion adjustments were required. However, this substitution resulted in the new D 2 model having overlapped side chains in TM2 and TM3 near the extracellular surface. The rhodopsin unwinding at GG is not favorable for the ␤-carbon containing residues in D 2 in this region. Thus, one might expect some steric hindrance. The backbone torsions (⌽,⌿ angles) of residues around the new Pro, particularly the four residues N-terminal to it (residues i to i-4), were adjusted to relieve the close contacts with TM3. These changes made the helix more regular (near Ϫ60°,Ϫ40°in ⌽,⌿) and accommodated the Pro side chain No energy minimization was performed nor were molecular dynamics run. This is in concert with our earlier modeling (Teeter et al., 1994) , based on calculations that show molecular mechanics techniques can distort a model that has been determined from a 1-Å resolution crystal structure (Whitlow and Teeter, 1986) .
Production of Cell Lines. Mutants of the rat D 2L receptor were constructed using the QuikChange mutagenesis kit (Stratagene, La Jolla, CA). Wild-type and mutant receptors in pcDNA3.1 were stably expressed in HEK293 cells by calcium phosphate precipitation, and clonal cell lines were isolated after selection with G418 (800 g/ml). Cell lines were maintained in Dulbecco's modified Eagle's medium supplemented with 5% iron-supplemented calf bovine serum, 5% fetal bovine serum, 600 g/ml G418, 0.05 U/ml penicillin, and 50 g/ml streptomycin at 37°C and 10% CO 2 .
Immunocytochemical Detection of the D 2 Receptor. Cells grown on glass coverslips were fixed in 4% paraformaldehyde/phosphate-buffered saline (58 mM Na 2 HPO 4 , 17 mM NaH 2 PO 4 , and 68 mM NaCl, pH 7.4) for 15 min, permeabilized in 0.5% Triton X-100 for 15 min, then blocked with 5% goat serum for 1 h at room temperature. Cells were incubated with rabbit anti-D2 receptor antiserum (AB5084P, 1/500 dilution; Chemicon International, Temecula, CA), washed, and incubated for 1 h with Oregon Green-tagged goat antirabbit IgG (1/100 dilution; Molecular Probes, Eugene, OR). The cells were washed, mounted onto a slide with Slowfade (Molecular Probes), and imaged with a Leica SP laser scanning confocal microscope (Leica, Deerfield, IL) .
[ Cheng and Prusoff (1973) . The free concentration of radioligand was calculated as the concentration added minus the concentration specifically bound. cAMP Accumulation Assay. The ability of D 2 receptor agonists to inhibit 30 M forskolin-stimulated cAMP accumulation was measured in intact cells. Cells were plated at a density of 18,000 cells/cm 2 in 48-well tissue culture plates and used in experiments 2 to 3 days later. Before the assay, cells were preincubated with Earle's balanced salt solution with 0.2% ascorbic acid and 2% calf bovine serum, pH 7.4, for 10 min at 37°C. The assay was terminated after 10 min by decanting the medium, and the cells were placed on ice and lysed with 3% trichloroacetic acid. Lysates were incubated on ice at least 30 min before cAMP accumulation was measured using a competitive protein binding assay as described previously (Watts and Neve, 1996) . Dose-response data were analyzed as described above for radioligand binding.
Results
Based on the crystal structure of rhodopsin (1F88 in the Protein Data Bank; Palczewski et al., 2000) a new model of the dopamine receptor was constructed ( Fig. 1A ; Teeter and DuRand, unpublished observations) . In this model, the sodium-binding pocket is similar to that in the previous model (Teeter et al., 1994) , except that Asn-124 3.42 is pointed away from the sodium site and hydrogen-bonds to 2.45 at the back side of tilted TM3. Conserved residue Asn-419 7.45 is now in the sodium-binding site, which has a pyramidal shape defined by side chain atoms of Asp-80 2.50 , Ser-121
, 7.46 at each vertex of the planar base, and the carbonyl oxygen of Asn-419 at the apex (Fig. 1B) . 7.49 stabilizes the pyramid by hydrogen-bonding to Asp-80 and to the carbonyl oxygen of Asn-419. In addition, the Asn-52
1.50 side chain hydrogen-bonds to Asp-80 ( Fig. 2A ) without changing rotamers, although a rotamer change had been proposed previously (Teeter et al., 1994) , and it also binds to the backbone carbonyl of Ser-420 on TM7. The sodium pocket region thus involves residues from TM1 (Asn-52), TM2 (Asp-80), TM3 (Ser-121), and TM7 (Asn-419, Ser-420) (Fig. 3) .
Three substitution mutants were constructed for both Asn-52 (N52A, N52Q, and N52L) and Ser-121 (S121A, S121N, S121L and antagonists that were tested, S121A had 4-to 5-fold enhanced affinity for haloperidol and clozapine, and a significantly decreased affinity for the agonists 7-OH-DPAT and dopamine ( Table 2) . Substitution of Asn for Ser-121 caused a 2-fold increase in the affinity of the receptor for clozapine and also caused a greater disruption of agonist binding compared with S121A, so that the affinity of S121N for dopamine, quinpirole, and 7-OH-DPAT was decreased 10-, 4-, and 25-fold, respectively.
The affinity and sodium-sensitivity of the binding of four antagonists, piquindone (Teeter and DuRand, 1996) and three substituted benzamide derivatives, was determined by inhibition of the binding of [ 3 H]spiperone in the presence and absence of 50 mM NaCl (Table 3 ; Fig. 5 ). The binding of the drugs to wild-type D 2L depended on the presence of sodium; the affinity of D 2L for the compounds was 13-to 48-fold greater in the presence than in the absence of sodium. The sodium sensitivity of binding to N52Q was similar to that of D 2L , so that the affinity of N52Q for the drugs was 13-to 106-fold greater in the presence of sodium. On the other hand, the sodium sensitivity of the binding of these antagonists to S121A and S121N was greatly reduced, so that affinities for the drugs were enhanced only 2-to 5-fold by the presence of sodium and, except for sulpiride at S121A, were more similar to K I values of the wild-type receptor obtained in the absence than in the presence of sodium.
The ability of agonists to activate the mutant receptors was determined by measuring inhibition of forskolin-stimulated cAMP accumulation (Table 4 ). All three of the mutant receptors that were capable of binding radioligands with high affinity also inhibited forskolin-stimulated cAMP accumulation; maximal inhibition was similar for the mutant and wild-type receptors (ϳ60% of total accumulation). Consistent with the decreased affinity of S121N for agonists, dopamine and quinpirole were significantly less potent at inhibition of cyclic AMP accumulation via S121N than the wild-type receptor.
To compare the sodium-binding pockets defined in the earlier homology model (Teeter et al., 1994 ) and the revised model, we constructed substitution mutants of Ser-420, which is part of the sodium site in both models, and Asn-124, which was suggested to be part of the sodium site in the earlier model but is pointed away from the sodium site in the revised model. All of the mutants bound [ 3 H]spiperone, in Fig. 2 . Conserved Asn-52 in TM1 and its interactions. A, Asn-52 (TM1) hydrogen-bonds to and to the carbonyl of Ser-420 (TM7). B, the N52Q mutation maintains the same hydrogen bonds (to Asp-80 and Ser-420 carbonyl) that are made by Asn-52. Amino acid residues that form the sodium-binding pocket or that interact with its residues are indicated. (Table 1 ). The affinity of N124A and N124L for most antagonists was decreased by 2-to 5-fold, whereas the mutation of N124Q was more deleterious, resulting in decreases in affinity of up to 30-fold (Table 5) . Nevertheless, mutation of Asn-124 tended to decrease the potency of sodium-sensitive drugs whether or not sodium was present, so that the magnitude of the sodium-dependent increase in affinity for substituted benzamide antagonists was similar for wild-type D 2L and all three Asn-124 mutants. In contrast, all four mutants of Ser-420 (S420A, S420L, S420N, and S420V) displayed a loss of affinity for substituted benzamide antagonists that was greater in the presence of sodium than in its absence, so that the effect of sodium on the binding of these antagonists was abolished (Table 6 ). As observed for Ala and Asn mutants of Ser-121, the affinity of S420A and S420N for clozapine and haloperidol was increased 2-to 9-fold compared with wild-type D 2L .
Discussion
A D 2 receptor model was built based on the crystal structure of rhodopsin (Palczewski et al., 2000) . When this model is viewed from the perspective of the arrow in Fig. 1A, , and Ser-420 7.46 at each vertex of the base, and Asn-419 backbone oxygen at the apex (Fig. 1B) . A sodium ion at the center of this site could form nearly ideal interactions, neutralizing the negative charge in this region. Four of these interactions appear to be closer (ϳ3 Å) than the others (ϳ4 Å). This differs from the previous model (Teeter et al., 1994) in several ways. First, conserved Asn-423 7.49 , the former apex, appears to be in sodium's second coordination shell (ϳ4 Å away). Asn-423 stabilizes the pocket by hydrogen-bonding to the new apex, the carbonyl oxygen of Asn-419, as well as to the side chain of Asp-80 at one vertex. Asn-419 is found one turn away from the highly conserved NP sequence 7.50 in D 2L ), at a potentially conserved bend in TM7 (Fu et al., 1996) . This bend frees the Asn-419 carbonyl oxygen to hydrogen-bond to the sodium ion. Second, Asn-124 3.42 has been replaced by Asn-419 at one of the vertices. Asn-124 is pointed away from the sodium site and hydrogen bonds to Ser-75 2.45 . In rhodopsin, the corresponding hydrogen bonding pair is Asn-78 on TM2 and Ser-127 on TM3 (Palczewski et al., 2000) , suggesting that this is a conserved interaction. Third, the side chains of Asn-419 and Ser-420 are hydrogen-bonded, further strengthening the sodium-binding pocket. Finally, the Asn-52 1.50 side chain hydrogen-bonds to Asp-80 ( Fig. 2A) , without changing rotamers as previously proposed (Teeter et al., 1994) , and also binds to the backbone carbonyl of Ser-420 on TM7. Both of these interactions as well as the exposed carbonyl of Asn-419 are conserved in the rhodopsin crystal structure (Palczewski et al., 2000) and are likely to be conserved in all G protein-coupled receptors.
We constructed mutants in which conservative or nonconservative substitutions were made for each of two polar amino acid residues postulated to contribute to the formation of the sodium-binding pocket (Ser-121 and Ser-420) for one residue thought to hydrogen-bond with the highly conserved aspartate residue Asp-80 (Asn-52) and for one residue that was predicted to be part of the sodium-binding pocket in our earlier model, but not in the revised model (Asn-124). Three of the six mutants, N52L, N52A, and S121L, were not detectable by radioligand binding, suggesting that the structure of the D 2 receptor is very sensitive to changes in the properties of the residues at these positions. Residues with nonpolar side chains, in particular, were not well tolerated. Immunocytochemical localization of the nonfunctional mutant receptors suggested that each was expressed and targeted to the cell membrane, although the mutant receptors may have been distributed less homogenously around the perimeter of the cell than was the wild-type D 2 receptor. Although conclu- 2L with regard to the potency of agonists and antagonists, sensitivity to sodium, and inhibition of forskolin-stimulated cyclic AMP accumulation. In our model, this is explained by the ability of Gln to preserve the postulated hydrogen-bonding interaction of the native Asn-52 with Asp-80 (Fig. 2B) . Interaction of Asn 1.50 with Asp 2.50 is also predicted by models of the TRH and ␣ 1B -adrenergic receptors, with mutagenesis data that support the interaction (Scheer et al., 1996; Perlman et al., 1997a) . Interestingly, substitution of Ala or Asp for Asn 1.50 in the TRH receptor (N43A and N43D) or the ␣ 1B -adrenergic receptor (N63A and N63D) has less severe consequences than substitution with Ala or Leu in the D 2 receptor in the present study. In the case of the TRH receptor, the mutants are detectable by ligand binding and are functional, albeit with reduced affinity for ligands, decreased density of expression, and decreased abil- ity to stimulate inositol phosphate formation (Perlman et al., 1997a) . N63A and N63D mutants (but not N63L or N63F mutants) of the ␣ 1B -adrenergic receptor also bind agonist and antagonist ligands with high affinity and stimulate inositol phosphate formation (Scheer et al., 1996) . Studies of the tachykinin NK 2 receptor suggest that the primary effect of mutation of Asn 1.50 to Asp or His (N51D and N51H) is to greatly reduce the expression of the receptors, without markedly altering the binding of ligands or functional coupling (Donnelly et al., 1999) . Similarly, an N33A
1.50 mutant of the HEK293 cells stably expressing the indicated wild-type or mutant D 2L receptor were incubated with 30 M forskolin and increasing concentrations of the indicated drugs, and cAMP formation was determined as described under Experimental Procedures. EC 50 values, expressed in nanomolar, were calculated from the dose-response curves and are the geometric means of three to five independent experiments, followed in parentheses by the limits defined by the asymmetrical S.E. The mean Ϯ S.E. is shown for maximal inhibition of forskolin-stimulated activity (Max), expressed as a percentage of total cAMP accumulation. Each value is the geometric mean of four to six independent experiments, followed in parentheses by the limits defined by the asymmetrical S.E. For the substituted benzamide derivates, the fold change in affinity resulting from the presence or absence of sodium (⌬sodium) is also given. Each value is the geometric mean of four to six independent experiments, followed in parentheses by the limits defined by the asymmetrical S.E. For the substituted benzamide derivates, the fold change in affinity resulting from the presence or absence of sodium (⌬sodium) is also given. platelet activating factor receptor binds agonist and antagonist radioligands (Ishii et al., 1997) . In the case of the peptide receptors, the less severe consequences of substituting Ala at this position, compared with the consequences for the D 2L receptor, could be caused by a different mode of ligand binding, which is primarily to the extracellular loops rather than to the transmembrane helices, but it is not clear why the Ala substitution at this position is better tolerated by the ␣ 1b -adrenergic receptor (Scheer et al., 1996) than by the D 2L receptor (present results). The deleterious consequences of the N52A substitution compared with the sparing of function in S121A is interesting. Ser-121 is part of the sodium site, which is an open cavity with considerable water around. Indeed, a water molecule is at the center of a site in the rhodopsin structure that corresponds to the presumed sodium-binding site in the D 2 receptor (Palczewski et al., 2000) . Thus, the sparing of function after replacement of Ser-121 with a nonpolar alanine residue in S121A is probably caused by a polar water molecule filling the space vacated by the lost hydroxyl of the serine side chain (Alber et al., 1987) . On the other hand, in our model, Asn-52's site has no cavity for water and is quite "tight" but hydrophilic, and the Ala substitution would therefore be more deleterious.
In addition to binding sodium, the polar pocket formed by Asn 1.50 , Asp 2.50 , and Asn 7.49 (Asn-423 in the D 2L receptor) has been postulated to be involved in regulating the equilibrium between active and inactive receptor conformations (Scheer et al., 1996) . According to this model, Arg 3.50 of the highly conserved Asp-Arg-Tyr (DRY) sequence at the base of TM3 is stabilized within the polar pocket by hydrogen-bonding and electrostatic interactions with Asn 1.50 and Asp 2.50 , and mutation of Asn 1.50 shifts Arg 3.50 out of the polar pocket, mimicking the active conformation of the receptor. However, in the rhodopsin crystal structure (Palczewski et al., 2000) and in our new D 2 receptor model, the distance between Arg 3.50 in the DRY (or ERY) sequence and either Asn 1.50 or Asp 2.50 is about 20 Å. Instead of interacting with TM1 and TM2, Arg 3.50 in the ERY in rhodopsin has a salt link with Glu-369 6.30 (D 2L numbering) in the TM6 helical extension. The S121A and S121N mutants of the D 2L receptor differed from the wild-type receptor in several respects. The affinity of the receptors for some antagonists (clozapine and haloperidol) was enhanced modestly, whereas there was a moderate decrease in affinity for several agonists. Both mutant receptors mediated agonist inhibition of adenylate cyclase, with decreases in agonist potency that roughly paralleled the decreased agonist affinity observed in ligand binding studies. The most robust effect of these mutations was to decrease the sodium sensitivity of the binding of those antagonists that have markedly higher affinity for the wild-type D 2 receptor in the presence of sodium. As was observed previously for the D80A mutant , regardless of the presence or absence of sodium, the affinity of the mutants for substituted benzamide derivatives was similar to that of the wild-type receptor in the absence of sodium. Similar results were observed for Ala and Asn substitutions of Ser-420, whereas Val or Leu substitution for Ser-420 abolished the sodium sensitivity of the receptor without increasing the affinity of the mutants for haloperidol and clozapine. In contrast, mutation of Asn-124 had little effect on the sodium sensitivity of the D 2L receptor, supporting the revised receptor model in which this residue is not predicted to be part of the sodium-binding pocket.
The S121N mutation caused decreased binding of benzamides despite the potential of the Asn to hydrogen-bond to sodium. This could be explained by direct interference of the larger Asn with the binding of benzamides. In our model, distances between Asn-121 and benzamide ligands are approximately 2 Å. Furthermore, the side chains of Asn-121 (TM3) and Asn-423 (TM7) could hydrogen-bond (distance 3.4 Å). In rhodopsin, TM3 and TM6 are shown to move apart at the interior in the activated receptor (Farrens et al., 1996) . TM7 also changes its position later in the rhodopsin photocycle . A hydrogen bond between TM3 and TM7 would constrain this movement. Ser-121 3.39 has been a target in mutagenesis studies of many G protein-coupled receptors, and a cysteine-scanning study indicates that the residue is within the water-accessible ligand binding pocket of the D 2 receptor (Javitch et al., 1995) . Ala mutants of this residue have been reported to not be expressed (␤ 2 -adrenergic receptor; Strader et al., 1989) , to be expressed but unable to bind ligands (adenosine A1 receptor; Barbhaiya et al., 1996) , or to be expressed and able to bind ligands but unable to stimulate inositol phosphate accumulation (AT 1 receptor; Monnot et al., 1996) . On the other hand, mutation of this residue to Ala has little or no effect on ligand binding or receptor signaling for the M 1 acetylcholine receptor (Lu and Hulme, 1999) and the platelet-activating factor receptor (Ishii et al., 1997) and little or no effect on ligand binding for the angiotensin II AT 1 receptor (Monnot et al., 1996; Perlman et al., 1997b) , the bradykinin B 2 receptor (Jarnagin et al., 1996) , and the adenosine A 2a receptor (Jiang et al., 1996) . The S123A mutant of the C5a chemotactic peptide receptor is also functional (Baranski et al., 1999) , as is the S115G mutant of the AT 1 receptor (Noda et al., 1996) . These studies are all consistent with our observation that mutation of Ser-121 to Ala or Asn had little effect on the binding of ligands to the D 2L receptor or the ability of the receptor to inhibit adenylate cyclase, but selectively altered the regulation of the receptor by sodium.
The question arises whether the sodium pocket, documented to be accessible from the cytoplasmic side only, is permeable to sodium ions in the new D 2 receptor model. This might be expected because of the proximity of the nonpolar ligand binding pocket to the water-accessible Ser-121 (see above). However, TM3 is tilted in rhodopsin and in our model, and Met-116 3.35 (first M in DVMM) lies to the extracellular side of the sodium pocket, partially blocking the path of sodium to the extracellular side but not occluding Ser-121 from that side. In addition, the nonpolar atoms of the pocket are incompatible with the polar sodium ion but well suited for ligand binding or disulfide bond formation by MTSEA. Although MTSEA has a polar end that demonstrates proximity to water, in cysteine-scanning studies, the alkyl sulfide end could access the Ser-121 site that has been mutated to the less polar Cys through the pocket. Thus, our model is consistent with these residues forming a sodium-binding pocket, as opposed to a pore or channel.
Mutation of the residue corresponding to Ser-420 7.46 to Ala had little effect on ligand binding to the ␤ 2 -adrenergic receptor (Strader et al., 1989) or the P2Y 1 purinoceptor (Jiang et al., 1997) , whereas the same mutation decreased the affinity of the 5HT 1A receptor (S393A) for agonists (Chanda et al., 1993) receptor affinity for agonists but not antagonists (Jiang et al., 1996) , whereas in the present study, the potency of several antagonist ligands for either S420A or S420N mutants of D 2L was enhanced. Consistent with the present results, the S391A 7.46 mutation of the short form of the D 2 receptor, D 2S , has little effect on the binding of most ligands but decreases the potency of substituted benzamide antagonists in the presence of sodium (Cox et al., 1992) . Because this residue is not exposed to the water-accessible ligand binding crevice (Fu et al., 1996) , effects of mutation of the residue on ligand affinity are probably indirect.
Asn-124 3.42 is not within the water-accessible ligand binding pocket of the D 2 receptor (Javitch et al., 1995) , and probably does not participate directly in the binding of ligands. The effects of mutation of this residue on ligand binding are probably secondary to disruption of helix packing. In this regard, it is interesting that replacing the polar Asn side chain with a polar but bulkier Gln side chain was more deleterious than substitution with nonpolar residues that are smaller than or similar in size to Asn. Mutation of the corresponding residue in the M 1 muscarinic receptor (N115A) has little effect on the function of that receptor (Lu and Hulme, 1999) .
In summary, these results support our hypothesis that Asn-52 and Ser-121 are crucial for maintaining the conformation of the ligand-binding pocket of the D 2L dopamine receptor, because certain nonconservative substitutions result in a profound loss of receptor function. Furthermore, the loss of sensitivity to sodium of the S121A and S121N mutants and all of the Ser-420 substitution mutants is in accord with our prediction that Ser-121 and Ser-420 participate in the formation of a sodium-binding pocket on the receptor.
